Clinical trials
Phase 2 trials in Latvia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
224 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2001 | 1 |
| 2002 | 1 |
| 2003 | 2 |
| 2004 | 2 |
| 2005 | 8 |
| 2006 | 10 |
| 2007 | 14 |
| 2008 | 15 |
| 2009 | 14 |
| 2010 | 14 |
| 2011 | 7 |
| 2012 | 14 |
| 2013 | 8 |
| 2014 | 5 |
| 2015 | 8 |
| 2016 | 11 |
| 2017 | 11 |
| 2018 | 9 |
| 2019 | 10 |
| 2020 | 12 |
| 2021 | 15 |
| 2022 | 7 |
| 2023 | 5 |
| 2024 | 11 |
| 2025 | 4 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 165 |
| Terminated | 36 |
| Active, not recruiting | 12 |
| Recruiting | 8 |
| Withdrawn | 2 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hoffmann-La Roche | 16 |
| GlaxoSmithKline | 15 |
| Boehringer Ingelheim | 9 |
| Novartis Pharmaceuticals | 9 |
| Amgen | 8 |
| Pfizer | 8 |
| AbbVie | 5 |
| Astellas Pharma Inc | 5 |
| Bayer | 5 |
| Lakefront Biotherapeutics NV | 5 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Colitis, Ulcerative | 16 |
| Diabetes Mellitus, Type 2 | 16 |
| Arthritis, Rheumatoid | 14 |
| Asthma | 12 |
| Venous Thromboembolism | 8 |
| Inflammatory Bowel Diseases | 7 |
| Epilepsy | 6 |
| Dermatitis, Atopic | 5 |
| Pulmonary Disease, Chronic Obstructive | 5 |
| Tuberculosis, Multidrug-Resistant | 5 |
Trials
Showing 1 to 25 of 224. Each trial links to its page on Pharma Observatory.
124 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.